Discussions

We provide a comprehensive suite of T cell antigen connector (TAC) services, including TAC design, construction, validation, and scale-up production. Our goal is to promote TAC-specific plasmid-based cell therapy into preclinical trials for a wide range of disease research. Nowadays, we have built a team of talented and motivated scientists and technicians to pursue our commitment.

Using a variety of expression vectors, we have built a library of TAC-specific plasmid products that include more than 1,000 tumor targets, and 25,000 different TAC design elements. Our products are ready to be used in pilot studies, for cloning purposes, or packaged as virus particles.